Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Efficacy of brain radiotherapy...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Efficacy of brain radiotherapy plus EGFR-TKI for 
EGFR-mutated NSCLC patients who develop brain metastasis

Efficacy of brain radiotherapy plus EGFR-TKI for EGFR-mutated NSCLC patients who develop brain metastasis

Bibliographic Details
Main Authors: Wenxian Wang, Zhengbo Song, Yiping Zhang
Format: Article
Language:English
Published: Termedia Publishing House 2018-10-01
Series:Archives of Medical Science
Subjects:
brain metastases
epidermal growth factor recptor tyrosine kinase inhibitors
non-small cell lung cancer
radiotherapy
Online Access:https://www.termedia.pl/Efficacy-of-brain-radiotherapy-plus-EGFR-TKI-for-r-nEGFR-mutated-NSCLC-patients-who-develop-brain-metastasis,19,33964,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:1734-1922
1896-9151

Similar Items

  • First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell Lung cancer with brain metastases: a systematic review and meta-analysis
    by: Yaowen Song, et al.
    Published: (2023-10-01)
  • Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases
    by: Yu Saida, et al.
    Published: (2019-11-01)
  • Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced EGFR-mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study
    by: He ZY, et al.
    Published: (2019-03-01)
  • Clinical Predictive Factors associated with First Line EGFR-TKI Efficacy 
in Advanced NSCLC Patients with EGFR Mutations
    by: Minjiang CHEN, et al.
    Published: (2019-02-01)
  • Targeting HER3 to overcome EGFR TKI resistance in NSCLC
    by: Qiuqiang Chen, et al.
    Published: (2024-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs